Ruxolitinib Phosphate-impurities | Pharmaffiliates

Ruxolitinib Phosphate

Ruxolitinib Phosphate, sold under the brand names Jakafi and Jakavi, is a medication for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow.Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. Reference standards of Ruxolitinib Phosphate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ruxolitinib Phosphate - API Standards 
    [catalogue_number] => PA 18 1110000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 404.37
    [form] => C17H21N6O4P
    [cas] => 1092939-17-7
    [pslug] => 1092939-17-7-ruxolitinib-phosphate-api-pa181110000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 1
    [offers_name] => Spring Season Offer
    [offers_status] => 1
    [offers_start_date] => 2024-03-27
    [offers_end_date] => 2024-03-31
    [pageview] => 2
    [offers_slug] => spring-season-offer
    [offers_product_id] => 3969
    [offers_product_code] => PA 18 1110000
    [offers_master_id] => 1
    [offer_percentage] => 20% OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards 
)
PA 18 1110000

Ruxolitinib Phosphate - API Standards


  • Catalogue No.:PA 18 1110000

  • CAS :

    1092939-17-7

  • Molecular Formula : C17H21N6O4P

  • Molecular Weight : 404.37